“European Society of Cardiology” anbefaler genotypingstest før behandling.

The "European Society of Cardiology" recommends genotyping tests before treatment.

“Pharmacogenomics” is the study of how a person’s genetic information affects their response to drugs. It examines the interaction between a person’s genetics and drugs to understand how individual genetic variations can affect the efficacy, effectiveness, and side effects of drugs. By identifying specific genetic markers Pharmacogenomics can help predict which drugs are most appropriate and effective for a given person, as well as help adjust the dosage of drugs to achieve the best therapeutic effect. Personalized Medical Profiling can therefore improve medical treatment and patient outcome. .

Read the article from the European Heart Journal – Cardiovascular Pharmacotherapy here.